ArticleACS omega2026
High-Throughput Microfluidic Synthesis of Biocompatible Carbon-Dot-Loaded Liposomes: Geometry-Dependent Encapsulation and CFD Analysis of Mixing.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microfluidic platforms offer precise control over nanocarrier synthesis but remain underexploited for low-cost production of multifunctional carbon dot-liposome (CDLiposome) systems. Here, we optimize the synthesis of CD-loaded liposomes using four PMMA micromixer geometriesSerpentine, SARS, Circular Features (CF), and Chambersand quantitatively link encapsulation performance, mixing physics, and computational fluid dynamics (CFD) models. All devices produced monodisperse vesicles with hydrodynamic diameters of ∼150-200 nm. Encapsulation experiments combining two total flow rates (TFR = 75 and 150 mL/h) and three flow rate ratios (FRR = 1:1, 1:2, and 2:1) revealed that FRR is the dominant parameter: a lipid-to-aqueous FRR of 2:1 yielded significantly higher encapsulation efficiencies across all geometries, whereas TFR had no statistically significant effect, enabling high-throughput operation at 150 mL/h. The Chambers device exhibited the best performance, achieving encapsulation efficiencies approaching 90%, followed by CF, SARS, and Serpentine. To rationalize these trends, we compared experimental mixing profiles with COMSOL Multiphysics simulations using Mixture and Euler-Euler frameworks and multiple RANS closures. At low TFR (2 mL/h), the Laminar model accurately reproduced PIV-validated velocity fields, whereas at higher TFRs (75-150 mL/h), an empirically tuned Custom 2 model was required to match the scalar mixing efficiency, demonstrating that no single RANS closure can simultaneously capture both momentum and scalar transport across regimes. Finally, MTT assays in Vero cells showed cell viabilities of ≥70% up to 400 μg/mL after 24 and 48 h, confirming high
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.